Verrica Pharmaceuticals Inc. (VRCA) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2017: -$4.58M2018: -$17.87M2019: -$27.41M2020: -$30.21M2021: -$27.58M2022: -$18.65M2023: -$38.58M2024: -$60.93M2025: -$17.63M-$17.63M
2017Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$17.63M+71.1%
2024-$60.93M-57.9%
2023-$38.58M-106.8%
2022-$18.65M+32.4%
2021-$27.58M+8.7%
2020-$30.21M-10.2%
2019-$27.41M-53.3%
2018-$17.87M-290.0%
2017-$4.58M